You are here

  • Home
  • Archive
  • Volume 92, Issue 2
  • Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study

Article metrics

Article menu
XML
Multiple sclerosis
Original research
Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study

 

Online download statistics by month:

Online download statistics by month: October 2020 to July 2022

AbstractFullPdf
Oct 2020881865110
Nov 2020865870376
Dec 2020328327245
Jan 2021590584152
Feb 202130329095
Mar 202120620464
Apr 202112712649
May 202115415656
Jun 202117717676
Jul 202110010042
Aug 202118118040
Sep 202114914849
Oct 202112512153
Nov 2021888851
Dec 202110610748
Jan 202212312151
Feb 202211712253
Mar 202211912255
Apr 202214114940
May 2022999743
Jun 2022777838
Jul 202210410130
Total516051321816